Leave Your Message

Changzhou Jiayuan Chemical: The Key Prostaglandin Intermediates and APIs in the Innovative Pharmaceutical Pipeline

2026-05-27

Release Date: May 27 2026 Source: 
Fluorochemical Products R&D Center, Changzhou Jiayuan Chemical Co., Ltd.

Changzhou Jiayuan Chemical Co., Ltd. focuses on the field of fluorochemistry and has built a complete industrial chain from fluorite to high - purity hydrogen fluoride, electronic-grade hydrofluoric acid, trifluorochloroethylene, octafluorocyclobutane, inorganic fluoride salt series, boron-10 acid, electronic specialty gases, and downstream high-end fluorinated liquids (such as HFE449), truly achieving vertical integration throughout the AI big data market.

Changzhou Jiayuan Chemical Co., Ltd., relying on its self-controllable raw material advantages and large-scale production capabilities, can ensure stable product quality and reliable supply from source to finished product. The company's products are widely used in cutting-edge fields such as precision manufacturing cleaning, electronic heat dissipation and cooling, new energy, and semiconductor testing, and the company is committed to providing global customers with high-performance, low-environmental-impact fluorochemical solutions.

Changzhou Jiayuan Chemical Co., Ltd. will continue to focus on the fluorochemical industry chain, promote the technological iteration and industrialization of green fluorosolvents, and contribute to the sustainable development of the industry.


I. Market Outlook and Industry Challenges

The number of glaucoma patients worldwide continues to rise. As first‑line intraocular pressure‑lowering agents for open‑angle glaucoma and ocular hypertension, prostaglandin‑based drugs  have maintained steady market demand. However, these compounds feature complex structures, multiple chiral centers, and lengthy synthetic routes, placing extremely high demands on the purity, stereochemistry, and impurity control of their intermediates. Driven both by generic drug consistency evaluation and innovative drug R&D, high‑quality, traceable intermediates and impurity reference standards have become a core bottleneck and an urgent need in drug development and manufacturing.

II. Prostaglandin Core Intermediates – The Common Building Blocks for Multiple Blockbuster Drugs

Prostaglandin drugs have intricate structures and multiple chiral centers, requiring very high‑quality intermediates . Core intermediates are the starting point of API synthesis and directly determine process feasibility and product quality.

Corey Lactone Series: Key chiral modules for the synthesis of latanoprost, travoprost, bimatoprost, etc., influencing yield and stereochemical control.

Bicyclic Lactone Series: Another important scaffold that, together with Corey lactones, provides a complete supply chain from scaffold construction to final API.

Advanced Protected Intermediates: Intermediates closer to the final API, requiring high purity and reflecting process sophistication.

III. Prostaglandin APIs – Full Coverage of Four Major Drugs

Latanoprost: One of the highest market‑share prostaglandin‑based intraocular pressure‑lowering drugs, widely used clinically as first‑line treatment for open‑angle glaucoma and ocular hypertension.

Travoprost: The first prostaglandin analogue approved by the FDA for first‑line treatment of glaucoma patients; its finished formulations hold a significant share in commercial production.

Bimatoprost: A synthetic prostaglandin amide analogue with strong intraocular pressure‑lowering effects, also extended to cosmetic applications such as eyelash growth.

Tafluprost: A next‑generation fluorinated prostaglandin analogue with a long synthetic route and many reaction steps, imposing extremely high quality requirements on intermediates.

tafluprost.jpg

IV. Supporting Impurity Reference Standards – Essential Tools for Quality Research and Consistency Evaluation

Impurity reference standards are indispensable for analytical method development, method validation, and quality control. For the four major prostaglandin APIs, we supply corresponding impurity reference standards (e.g., travoprost impurities, bimatoprost/latanoprost‑related impurities, etc.). These can serve as high‑quality analytical standards for ANDA filing, including method development, validation, and QC applications, helping customers effectively control product quality and mitigate compliance risks.

V. Other Pharmaceutical Intermediates and Reference Standards

Beyond the prostaglandin series, we also supply a variety of general organic chemical intermediates(e.g., compounds containing pyridine, triazole, nicotinic acid structures, etc.) as well as key intermediates for adapalene (6‑bromo‑2‑naphthoic acid and its methyl ester). The former are widely used in antifungal, anticancer, COX inhibition, and metal extraction applications; the latter are core synthetic intermediates and USP reference standards for adapalene, a third‑generation retinoid, covering the entire process from API production to quality control.

VI. Summary

Changzhou Jiayuan Chemical can supply key intermediates and finished APIs for prostaglandin drugs, while also covering other pharmaceutical intermediates such as those for adapalene. The company provides HPLC testing, multiple packaging options, and products that span from laboratory‑scale R&D to commercial production. Going forward, we will continue to optimize product quality and supply stability, striving to become your reliable partner. For more information or to discuss your needs, please feel free to contact Changzhou Jiayuan Chemical by email or phone.